CCL2 and chronic kidney disease: Silveira et al. (2019) demonstrated that the consumption of 500 mg/day of standardized propolis extract significantly reduced proteinuria and the urinary level of monocyte chemoattractant protein-1 (MCP-1), an inflammation marker, in a randomized, double-blind, placebo-controlled trial in patients with chronic kidney disease [125].